Treatment of hypertrophic obstructive cardiomyopathy with verapamil.

Twenty-two patients with hypertrophic obstructive cardiomyopathy were treated with the calcium inhibitor, verapamil, which was administered in a mean oral dose of 480 mg per day. After an average of 15 months of treatment (4 to 24 months), the QRS amplitude in the electrocardiogram was significantly...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Br Heart J
Principais autores:	Kaltenbach, M, Hopf, R, Kober, G, Bussmann, W D, Keller, M, Petersen, Y
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMJ Publishing Group 1979
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC482109/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/573129/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.42.1.35
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!